Resveratrol

📋 Overview

Resveratrol is a naturally occurring polyphenol stilbenoid found in the skin of red grapes, blueberries, raspberries, mulberries, and peanuts — and most famously in red wine, which sparked widespread interest in its health properties following epidemiological observations linking moderate red wine consumption to reduced cardiovascular mortality (the "French Paradox"). Resveratrol is a potent activator of SIRT1 — the founding member of the sirtuin longevity gene family — and this mechanism links it directly to caloric restriction mimicry, DNA repair, and metabolic regulation. David Sinclair's laboratory at Harvard identified resveratrol as a sirtuin-activating compound (STAC) in 2003, triggering an explosion of research interest. While some early findings have proven difficult to replicate and resveratrol's bioavailability is notoriously poor, it remains one of the most extensively studied polyphenols in longevity science. Its combination with NMN — resveratrol activating sirtuins while NMN provides the NAD+ fuel they require — is a popular longevity stack with a logical mechanistic rationale.

🌿 Key Benefits

⚙️ How It Works

1. SIRT1 Activation — Resveratrol activates SIRT1 directly as a sirtuin-activating compound (STAC), and indirectly by inhibiting phosphodiesterases (PDEs) which increases cAMP and activates AMPK — which in turn activates SIRT1. This creates a cascade that mimics many of the cellular effects of caloric restriction.
2. AMPK Activation — Through PDE inhibition and direct effects, resveratrol activates AMPK — the master metabolic sensor — improving insulin sensitivity, mitochondrial function, and fat oxidation.
3. NF-κB Inhibition — Resveratrol inhibits nuclear factor-kappa B (NF-κB) — the master inflammatory transcription factor — reducing production of inflammatory cytokines and providing systemic anti-inflammatory effects.
4. Antioxidant Activity — Resveratrol directly scavenges free radicals and upregulates endogenous antioxidant enzymes, protecting LDL cholesterol from oxidation — a key step in cardiovascular disease progression.

🔬 What the Research Shows

Cardiovascular research shows resveratrol reduces LDL oxidation, improves endothelial function, and reduces inflammatory markers in human trials. A meta-analysis found resveratrol significantly reduced systolic blood pressure and fasting glucose. Metabolic research shows improved insulin sensitivity in insulin-resistant subjects. SIRT1 activation has been confirmed in human tissue. However, resveratrol's bioavailability is poor — it is rapidly metabolized and excreted, meaning very high doses or enhanced formulations are needed to achieve plasma concentrations that match in vitro effective doses. Pterostilbene — a methylated resveratrol analog — has better bioavailability and is emerging as a more effective alternative in some research.

💊 How to Use

• Typical dose: 150–500mg trans-resveratrol daily
• Bioavailability enhancement: Take with a fatty meal — fat significantly improves resveratrol absorption; some formulations use micronization or liposomal delivery for better bioavailability
• Timing: With meals — particularly with dietary fat
• Combine with: NMN for the complementary NAD+/sirtuin longevity stack; quercetin for synergistic anti-inflammatory effects
• Form: Trans-resveratrol is the active isomer — ensure products specify trans-resveratrol not cis-resveratrol

⚠️ Side Effects & Safety

Generally well tolerated at typical doses. Common side effects at higher doses include GI discomfort, nausea, and diarrhea. May have mild blood-thinning effects — caution with anticoagulant medications. At very high doses (above 1g daily) some studies show potential pro-oxidant effects — stay within reasonable dosing ranges. May interact with cytochrome P450 enzymes affecting metabolism of certain medications. Not recommended during pregnancy.

🔗 Related Supplements

NMN | Quercetin | CoQ10 | Spermidine

📚 References

1. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006.
2. Hausenblas HA, et al. Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus — systematic review and meta-analysis. Mol Nutr Food Res. 2015.